Intercos【ICOS】銘柄情報

Intercos Spa (ICOS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

12.00

( -0.99% )

買値

11.80

売値

12.36

出来高

55,194

12.04 日の範囲 12.34

10.42 52 週間の範囲 14.26

時価総額

1.156B

前日終値

12.12

始値

12.04

時刻

177

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

90,617 €

発行済株式数

96,364,020

配当利回り

0.2 (1.65%)

PER

23.76

1 株当たり利益 (EPS)

0.51

歳入

1.05B

純利益

49.83M

Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, derm... Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, dermo cosmetic lotions, and hair care products. The company sells its products to multinational brands, emerging brands, and retailers. Intercos S.p.A. was founded in 1972 and is headquartered in Agrate Brianza, Italy. 詳細を表示

セクター

Consumer Staples

業界

Consumer Products - Household & Personal

ウェブサイト

www.intercos.com

本社

Agrate Brianza, Italy

設立

1972

Intercos Spa is listed in the Consumer Staples sector of the イタリア証券取引所 with ticker ICOS. The last closing price for Intercos was 12.12 €. Over the last year, Intercos shares have traded in a share price range of 10.42 € to 14.26 €.

Intercos currently has 96,364,020 shares in issue. The market capitalisation of Intercos is 1.16 € billion. Intercos has a price to earnings ratio (PE ratio) of 23.76.

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

- Worldwide Sales of Cialis Top $233 Million - - Net Income Grows to $75.8 Million for 2006 Second Quarter - BOTHELL, Wash., and INDIANAPOLIS...

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

New Survey Reveals State of Emotional and Physical Intimacy of Boomer Relationships BOTHELL, Wash. and INDIANAPOLIS, June 22...

Lilly ICOS LLC Reports Results for First Quarter of 2006

- Cialis Attains Leading ED Market Share Position in Eleven Countries - BOTHELL, Wash. and INDIANAPOLIS, Ind., April 20 /PRNewswire-FirstCall/...

Lilly ICOS LLC Reports First Full-Year Profit in its History

- 2005 Fourth Quarter Net Income Surges to $61.4 Million - - 2005 Worldwide Sales Grow 35% - - Company Provides Update on Clinical Plan for BPH...

Lilly ICOS LLC Reports First Quarterly Profit in its History

BOTHELL, Wash. and INDIANAPOLIS, Ind., Oct. 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS) (NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS) is...

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

-- National Survey Shows Misconceptions Still Prevalent: Nearly One in Three Believe Tight Underwear Can Lead to Erectile Dysfunction NEW YORK...

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since...

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level -- Luke Donald Artwork, Original Vignettes...

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions SAN...

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France - Cialis Achieves 49% of Total Tablet...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.08	-0.662251655629	12.08	12.34	11.62	35960	11.9765607	DE
4	-0.3	-2.43902439024	12.3	12.66	11.54	72885	12.03125007	DE
12	0.52	4.52961672474	11.48	12.8	11.2	90930	12.13049645	DE
26	0.62	5.44815465729	11.38	13.2	10.58	103512	11.92615027	DE
52	-1.36	-10.1796407186	13.36	14.26	10.42	97471	11.98110487	DE
156	-2.88	-19.3548387097	14.88	16.92	10.42	81134	13.43545901	DE
260	-2.464	-17.0353982301	14.464	17.1	9.755	71565	13.50002994	DE